tm logo

Monitor this mark

View On USPTO

SENSIPAR
Live/Registered
REGISTERED AND RENEWED

on 04 Sep 2024

Last Applicant/ Owned by

Amgen Inc.

One Amgen Center Drive

Thousand Oaks

CA

91320-1799

Serial Number

76200460 filed on 26th Jan 2001

Registration Number

2867132 registered on 27th Jul 2004

in the Principal Register

Correspondent Address

Elsa D. Lemoine

Elsa D. Lemoine Amgen Inc.

Trademark Operations MS 28-5-A

Thousand Oaks, CA 91320-1799

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

SENSIPAR

Pharmaceutical products, namely, pharmaceuticals for modulating the level of calcium in the bloodstream and for the treatment of hyperparathyroidism and hypercalcemia

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical products, namely, pharmaceuticals for modulating the level of calcium in the bloodstream and for the treatment of hyperparathyroidism and hypercalcemia

First Use Date in General

06th Apr 2004

First Use Date in Commerce

06th Apr 2004

Mark Details

Serial Number

No 76200460

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM-1268-US-2

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
04th Sep 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04th Sep 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04th Sep 2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
12th Jul 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
11th Jul 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9
11th Jul 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12th Apr 2024TEAS SECTION 8 & 9 RECEIVED
27th Jul 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
29th Apr 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
29th Apr 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED